1:14-cv-00778 - Allos Therapeutics Inc et al. v. Dr Reddys Laboratories Ltd et al.Report Error
Detail
Case Number
1:14-cv-00778Current Status
closedCause of Action
Infringement
Related Case(s)
N/ACourt
Delaware District CourtPlaintiff(s)
Allos Therapeutics Inc
Southern Research Institute
Sloan Kettering Institute For Cancer Research
Sri International Inc
UniversityDefendant(s)
Dr Reddys Laboratories Ltd
Teva Pharmaceuticals International GMBH
Sandoz AG
Fresenius Kabi AB
Judge
Richard G. AndrewsFiling Date
2014-06-19Termination Date
2016-08-17Dockets
Text |
---|
CIVIL DOCKET |
UPDATED CIVIL DOCKET |
Summons Issued with Magistrate Consent Notice attached as to Dr Reddy`s Laboratories Inc. on 6/19/2014; Fresenius Kabi USA LLC on 6/19/2014; Sandoz Inc. on 6/19/2014; Teva Pharmaceuticals USA Inc. on 6/19/2014. (jeb, ) (Entered: 06/20/2014) |
Summons issued with Magistrate Consent Notice attached as to Dr Reddy`s Laboratories Ltd. (rbe) Modified on 6/20/2014 (rbe). Summons picked up at the Help Desk (Entered: 06/20/2014) |
COMPLAINT for Patent Infringement filed against Dr Reddy`s Laboratories Inc., Dr Reddy`s Laboratories Ltd, Fresenius Kabi USA LLC, Sandoz Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 21573.) - filed by Southern Research Institute, Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(jeb, ) (Entered: 06/20/2014) |
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jeb, ) (Additional attachment(s) added on 6/20/2014: # 1 Acknowledgement of Consent Form) (jeb, ). (Entered: 06/20/2014) |
MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Samantha L. Maxfield and Elizabeth J. Thompson - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Attachments: # 1 Lombardi Pro Hac Certification, # 2 Maxfield Pro Hac Certification, # 3 Thompson Pro Hac Certification)(Haney, Megan) (Attachment 1 replaced on 7/25/2014) (nms). (Entered: 07/24/2014) |
ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against Allos Therapeutics Inc. by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Attachments: # 1 Certificate of Service)(Seitz, George) Modified on 8/1/2014 (nms). (Entered: 07/31/2014) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddys Laboratories, Ltd. for Dr Reddys Laboratories Inc., Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Attachments: # 1 Certificate of Service)(Seitz, George) (Entered: 07/31/2014) |
MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Attachments: # 1 Pro Hac Certification of Maureen L. Rurka)(Haney, Megan) (Entered: 08/26/2014) |
MOTION for Pro Hac Vice Appearance of Attorney Lesley M. Hamming - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Attachments: # 1 Certification of Lesley M. Hamming)(Haney, Megan) (Entered: 12/30/2014) |
MOTION for Pro Hac Vice Appearance of Attorney Mary T. McCarthy - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Attachments: # 1 McCarthy Pro Hac Certification)(Haney, Megan) (Entered: 03/24/2015) |
MOTION for Pro Hac Vice Appearance of Attorney Dan H. Hoang - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Attachments: # 1 Certification)(Bilson, David) Modified on 5/27/2015 (nms). (Entered: 05/26/2015) |
Joint MOTION to Stay against Dr. Reddys - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Attachments: # 1 Proposed Order)(Maguire, Lauren) Modified on 6/29/2015 (nms). (Entered: 06/29/2015) |
MOTION for Pro Hac Vice Appearance of Attorney Ivan M. Poullaos - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Attachments: # 1 Certification of Ivan M. Poullaos)(Haney, Megan) (Entered: 02/12/2016) |
MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner and Erin Solomon - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Attachments: # 1 Certification of Kevin E. Warner, # 2 Certification of Erin Solomon)(Haney, Megan) (Entered: 02/25/2016) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,028,071; 7,622,470; 8,299,078. (Attachments: # 1 Consent Judgment)(nms) (Entered: 08/17/2016) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) pertaining to defendant Sandoz Inc. - Date Patentee(s) Received Notice: May 15, 2014. Date of Expiration of Patent: July 16,2022.Thirty Month Stay Deadline: 3/24/2017 See attached.(jeb, ) (Entered: 06/20/2014) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA)pertaining to defendant Fresenius Kabi USA, LLC - Date Patentee(s) Received Notice: May 7, 2014. Date of Expiration of Patent: July 16, 2022.Thirty Month Stay Deadline: 3/24/2017. See Attached. (jeb, ) (Entered: 06/20/2014) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA)pertaining to defendant Teva Pharmaceuticals USA, Inc. - Date Patentee(s) Received Notice: May 22,2014. Date of Expiration of Patent: July 16,2022.Thirty Month Stay Deadline: 3/24/2017. (jeb, ) (Entered: 06/20/2014) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) pertaining to defendants Dr. Reddy`s Laboratories, Ltd. and Dr. Reddy`s Laboratories, Inc. - Date Patentee(s) Received Notice: May 23,2014. Date of Expiration of Patent: July 16,2022.Thirty Month Stay Deadline: 3/24/2017. (jeb, ) (Entered: 06/20/2014) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,028,071; 7,622,470; 8,299,078;. (jeb, ) (Entered: 06/20/2014) |
SUMMONS Returned Executed by Southern Research Institute, Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research. Teva Pharmaceuticals USA Inc. served on 6/19/2014, answer due 7/10/2014. (Mayo, Andrew) (Entered: 06/20/2014) |
SUMMONS Returned Executed by Southern Research Institute, Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research. Fresenius Kabi USA LLC served on 6/19/2014, answer due 7/10/2014. (Mayo, Andrew) (Entered: 06/20/2014) |
AFFIDAVIT of Service for Complaint and Summons served on Sandoz Inc. on June 19, 2014, filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 06/25/2014) |
STIPULATION TO EXTEND TIME for Teva Pharmaceuticals USA, Inc., Sandoz Inc. and Fresenius Kabi USA, LLC to Respond to the Complaint to July 24, 2014 - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 06/26/2014) |
STIPULATION TO EXTEND TIME for Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc. to Respond to the Complaint to July 31, 2014 - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 06/26/2014) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Spectrum Pharmaceuticals, Inc. for Allos Therapeutics Inc.; Corporate Parent no corporate parent or other affiliate for SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 07/09/2014) |
ANSWER to 1 Complaint, Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by Sandoz Inc..(Phillips, John) (Entered: 07/24/2014) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Phillips, John) (Entered: 07/24/2014) |
ANSWER to 1 Complaint, Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by Fresenius Kabi USA LLC.(Phillips, John) (Entered: 07/24/2014) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius SE & Co. KGaA for Fresenius Kabi USA LLC filed by Fresenius Kabi USA LLC. (Phillips, John) (Entered: 07/24/2014) |
ANSWER to 1 Complaint, Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by Teva Pharmaceuticals USA Inc..(Phillips, John) (Entered: 07/24/2014) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA Inc. filed by Teva Pharmaceuticals USA Inc.. (Phillips, John) (Entered: 07/24/2014) |
MOTION for Pro Hac Vice Appearance of Attorney Mark H. Izraelewicz, Matthew C. Nielsen, Thomas I. Ross, Michael R. Weiner, and Amanda K. Antons - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 07/28/2014) |
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 9/5/2014, at 10:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/5/2014. (nms) (Entered: 08/04/2014) |
Letter to The Honorable Richard G. Andrews from George H. Seitz, III, Esquire regarding Scheduling conference date conflict - re 24 Order Setting Scheduling Conference. (Seitz, George) (Entered: 08/05/2014) |
ANSWER to 14 Answer to Complaint, Counterclaim by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 08/18/2014) |
ANSWER to 16 Answer to Complaint, Counterclaim by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 08/18/2014) |
ANSWER to 18 Answer to Complaint, Counterclaim by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 08/18/2014) |
MOTION for Pro Hac Vice Appearance of Attorney Martin B. Pavane, Esq., Julia S. Kim, Esq., Marilyn Neiman, Esq., and Darren S. Mogil, Esq. - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 08/19/2014) |
ANSWER to 22 Answer to Complaint, Counterclaim,, by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 08/25/2014) |
Letter to The Honorable Richard G. Andrews from Steven J. Balick regarding the parties proposed scheduling order. (Balick, Steven) (Entered: 08/29/2014) |
PROPOSED Scheduling Order, by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Balick, Steven) Modified on 8/29/2014 (nms). (Entered: 08/29/2014) |
Letter to The Honorable Richard G. Andrews from Steven J. Balick regarding the parties jointly proposed scheduling order. (Balick, Steven) (Entered: 09/11/2014) |
PROPOSED ORDER by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Balick, Steven) (Entered: 09/11/2014) |
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 6/26/2015. Amended Pleadings due by 6/26/2015. Fact Discovery due by 9/25/2015. Dispositive Motions due by 3/25/2016. Joint Claim Construction Brief due by 8/14/2015. A Markman Hearing is set for 8/27/2015, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 8/26/2016, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 4 day Bench Trial is set for 9/12/2016, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/12/2014. (nms) (Entered: 09/12/2014) |
ORDER Setting Teleconference: Plaintiffs counsel to initiate the call. A Telephone Conference is set for 9/25/2014 at 09:00 AM EASTERN TIME before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 9/12/14. (cak) (Entered: 09/12/2014) |
STIPULATION TO EXTEND TIME To Submit Proposed Protective Order to October 1, 2014 - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Phillips, John) (Entered: 09/23/2014) |
STIPULATION TO EXTEND TIME to submit a proposed protective order to October 15, 2014 - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Maguire, Lauren) (Entered: 10/01/2014) |
NOTICE OF SERVICE of Plaintiffs Disclosures Pursuant to Paragraph 4(a) of the Courts Default Standard for Discovery filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Maguire, Lauren) (Entered: 10/07/2014) |
STIPULATION TO EXTEND TIME to Serve Initial Disclosures and Default Standard Paragraph 3 Disclosures to November 7, 2014 - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Phillips, John) (Entered: 10/10/2014) |
STIPULATION TO EXTEND TIME to submit a proposed protective order to October 29, 2014 - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 10/15/2014) |
PROPOSED Stipulated Protective Order, by Allos Therapeutics Inc.. (Mayo, Andrew) Modified on 10/30/2014 (nms). (Entered: 10/29/2014) |
SO ORDERED Granting 44 Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 10/30/2014. (nms) (Entered: 10/30/2014) |
STIPULATION to extend time for Dr. Reddys Laboratories to serve written discovery, by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 11/03/2014) |
NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.s Initial Disclosures; (2) Defendant Fresenius Kabi USA, LLCs Initial Disclosures; and (3) Defendant Sandoz, Inc.s Initial Disclosures filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 11/07/2014) |
NOTICE OF SERVICE of Plaintiffs Initial Disclosures Pursuant to Paragraph 3 of the Courts Default Standard for Discovery and Plaintiffs Rule 26(a)(1) Initial Disclosures filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Main Document 49 replaced on 11/10/2014) (nms). (Entered: 11/07/2014) |
NOTICE Of Service of Defendants Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc.s Default Paragraph 4(b) Standard Disclosures and Anda Production, filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd.(Seitz, George) Modified on 11/12/2014 (nms). (Entered: 11/11/2014) |
STIPULATION TO EXTEND TIME Time t file Disclosures to 12/05/14 - filed by Dr Reddys Laboratories Inc.. (Seitz, George) (Entered: 11/12/2014) |
NOTICE OF SERVICE of (1) Defendants First Set of Rule 34 Requests to Plaintiffs (Nos. 1-54) and (2) Defendants First Set of Interrogatories to Plaintiffs (Nos. 1-7) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 12/03/2014) |
STIPULATION TO EXTEND TIME Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc. to serve Initial Disclosures to Paragraph 3 of the Courts Default Standard for Discovery and Rule 26(a)(1) to December 10, 2014 - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 12/05/2014) |
NOTICE of Service of Defendants Dr. Reddys Laboratories, LTD adn Dr. Reddys Laboratories, Inc.s Initial Disclosures, by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) Modified on 12/10/2014 (nms). (Entered: 12/10/2014) |
NOTICE OF SERVICE of Plaintiffs Disclosures Pursuant to Paragraph 4(c) of the Courts Default Standard for Discovery filed by Allos Therapeutics Inc..(Mayo, Andrew) (Entered: 12/19/2014) |
NOTICE OF SERVICE of Plaintiffs Requests for Production of Documents and Things to Defendants filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 12/23/2014) |
NOTICE OF SERVICE of Plaintiffs Response to Defendants First Set of Rule 34 Requests (Nos. 1-54) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 01/08/2015) |
NOTICE OF SERVICE of Plaintiffs First Set of Common Interrogatories to Defendants (Nos. 1-2) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 01/16/2015) |
NOTICE OF SERVICE of (1) Defendant Fresenius Kabi USA, LLCs Objections and Responses to Plaintiffs First Set of Requests for Production of Documents and Things (Nos. 1-70); (2) Defendant Sandoz Inc.s Objections and Responses to Plaintiffs First Set of Requests for Production of Documents and Things (Nos. 1-70); and (3) Defendant Teva Pharmaceuticals USA, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Production of Documents and Things (Nos. 1-70) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 01/22/2015) |
NOTICE OF SERVICE of Plaintiffs Response to Defendants First Set of Interrogatories (No. 1-7) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 01/29/2015) |
NOTICE OF SERVICE of Defendants Second Set of Rule 34 Requests to Plaintiffs (Nos. 55-61) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 02/02/2015) |
STIPULATION TO EXTEND TIME Default Standard Paragraph 4(d) Disclosures and for Substantial Completion of Document Production to March 13, 2015 and April 10, 2015, respectively - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Haney, Megan) (Entered: 02/03/2015) |
NOTICE OF SERVICE of (1) Defendant Sandoz Inc.s Objections and Responses to Plaintiffs First Set of Common Interrogatories to Defendants (Nos. 1-2); (2) Defendant Teva Pharmaceuticals USA, Inc.s Objections and Responses to Plaintiffs First Set of Common Interrogatories to Defendants (Nos. 1-2); and (3) Defendant Fresenius Kabi USA, LLCs Objections and Responses to Plaintiffs First Set of Common Interrogatories to Defendants (Nos. 1-2) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 02/18/2015) |
STIPULATION TO EXTEND TIME time to serve default standard paragraph 4d disclosures to April 3, 2015 for Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc. AND March 20, 2015 for Teva Pharmaceuticals USA, Inc., Sandoz Inc., and Fresenius Kabi USA, LLC - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 03/03/2015) |
NOTICE OF SERVICE of Plaintiffs Response to Defendants Second Set of Rule 34 Requests (Nos. 55-61) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 03/04/2015) |
STIPULATION TO EXTEND TIME for the parties to exchange lists of claim term(s) and phrase(s) that they believe require construction to March 20, 2015 - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) Modified on 3/13/2015 (nms). (Entered: 03/13/2015) |
NOTICE of Appearance by David A. Bilson on behalf of Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc. (Bilson, David) (Entered: 03/13/2015) |
NOTICE OF SERVICE of Plaintiffs Identification of Claim Terms/Phrases for Construction filed by Allos Therapeutics Inc..(Maguire, Lauren) (Entered: 03/20/2015) |
NOTICE OF SERVICE of (1) Defendants Preliminary Invalidity Contentions; and (2) Defendants Identification of Terms for Construction filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Phillips, John) (Entered: 03/20/2015) |
STIPULATION TO EXTEND TIME for the parties to substantially complete document production to May 8, 2015 - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Haney, Megan) (Entered: 03/25/2015) |
STIPULATION TO EXTEND TIME Default Standard Paragraph 4d disclosures by Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc. AND substantial completion of document production by Dr. Reddys to April 3, 2014 to April 20, 2015 AND April 10, 2015 to July 15, 2015 - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 04/02/2015) |
STIPULATION TO EXTEND TIME for Exchange of Proposed Claim Constructions to April 10, 2015 - filed by Dr Reddys Laboratories Inc.. (Seitz, George) (Entered: 04/03/2015) |
NOTICE OF SERVICE of Defendants Third Set of Rule 34 Requests to Plaintiffs (Nos. 62-69) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Bilson, David) (Entered: 04/08/2015) |
NOTICE OF SERVICE of Plaintiffs Proposed Claim Constructions filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 04/10/2015) |
NOTICE Of Service of Defendants Initial Proposed Claim Construction of Claim Terms, filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Bilson, David) Modified on 4/13/2015 (nms). (Entered: 04/10/2015) |
NOTICE OF SERVICE of Plaintiffs Disclosure Regarding Rebuttal Claim Construction Evidence filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Balick, Steven) (Entered: 04/17/2015) |
NOTICE OF SERVICE of Defendants Identification of Rebuttal Evidence in Support of Their Proposed Claim Construction of Claim Terms filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Bilson, David) (Entered: 04/17/2015) |
STIPULATION TO EXTEND TIME for the parties to submit the Joint Claim Construction Chart to May 1, 2015 - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 04/24/2015) |
NOTICE requesting Clerk to remove Elizabeth J. Thompson as co-counsel. Reason for request: No Longer Affiliated with Winston & Strawn LLP. (Bilson, David) (Entered: 04/27/2015) |
STIPULATION TO EXTEND TIME For Substantial Completion of Document Production to May 22, 2015 - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Phillips, John) (Entered: 04/30/2015) |
STIPULATION TO EXTEND TIME for default standard paragraph 4d disclosures by Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc. to May 29, 2015 - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 04/30/2015) |
STIPULATION and Proposed Order regarding Claim Construction by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 05/01/2015) |
NOTICE OF SERVICE of Plaintiffs Response to Defendants Third Set of Rule 34 Requests (Nos. 62-69) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 05/08/2015) |
NOTICE requesting Clerk to remove Mary T. McCarthy as co-counsel. Reason for request: No Longer Affiliated with Winston & Strawn LLP. (Bilson, David) (Entered: 05/26/2015) |
STIPULATION TO EXTEND TIME Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc.s deadline for default standard paragraph 4d disclosures to June 12, 2015 - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 05/29/2015) |
STIPULATION TO EXTEND TIME default standard paragraph 4d disclosures by Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc. to June 26, 2015 - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 06/10/2015) |
NOTICE OF SERVICE of Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 3-8) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 06/23/2015) |
NOTICE OF SERVICE of Plaintiffs First Set of Individual Interrogatories to Teva Pharmaceuticals USA, Inc. (Nos. 1-3) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 06/24/2015) |
STIPULATION TO EXTEND TIME for default standard paragraph 4d disclosures by Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc. to July 2, 2015 - filed by Dr Reddys Laboratories Inc., Dr Reddys Laboratories Ltd. (Seitz, George) (Entered: 06/25/2015) |
ORDER Granting 93 Joint MOTION to Stay against Dr. Reddys. Signed by Judge Richard G. Andrews on 6/29/2015. (nms) (Entered: 06/30/2015) |
NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.s Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 3-8); (2) Defendant Sandoz Inc.s Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 3-8); (3) Defendant Fresenius Kabi USA, LLCs Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 3-8) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 07/23/2015) |
NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.s Objections and Responses to Plaintiffs First Set of Individual Interrogatories to Teva Pharmaceuticals USA, Inc. (Nos. 1-3); and (2) Defendants Second Set of Interrogatories to Plaintiffs (Nos. 8-11) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 07/24/2015) |
NOTICE OF SERVICE of (1) Defendant Sandoz Inc.s Amended Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 3-8); (2) Defendant Fresenius Kabi USA, LLC.s Amended Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 3-8); (3) Defendant Teva Pharmaceuticals USA, Inc.s Amended Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 3-8) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 07/29/2015) |
STIPULATION TO EXTEND TIME to Amend Scheduling Order to Various (See Order) - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Phillips, John) (Entered: 08/13/2015) |
NOTICE OF SERVICE of Plaintiffs Response to Defendants Second Set of Interrogatories (Nos. 8 - 11) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 08/27/2015) |
NOTICE OF SERVICE of Defendants Third Set of Interrogatories to Plaintiffs (Nos. 12-14) filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 10/21/2015) |
NOTICE to Take Deposition of Plaintiff Southern Research Institute Pursuant to Fed. R. Civ. P. 30(b)(6) on December 18, 2015 at 9:00 a.m. filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 11/06/2015) |
NOTICE to Take Deposition of Plaintiff Allos Therapeutics, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on December 15, 2015 at 9:00 a.m. filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 11/06/2015) |
NOTICE to Take Deposition of Plaintiff SRI International, Inc. Pursuant to Fed.R. Civ. P. 30(b)(6) on December 17, 2015 at 9:00 a.m. filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 11/06/2015) |
NOTICE to Take Deposition of Plaintiff Sloan-Kettering Institute for Cancer Research Pursuant to Fed. R. Civ. P. 30(b)(6) on December 16, 2015 at 9:00 a.m. filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 11/06/2015) |
NOTICE of Subpoena for the Production of Documents and Notice of Subpoena for Deposition to Dr. Owen A. OConnor by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc. (Haney, Megan) (Entered: 11/13/2015) |
NOTICE of Subpoena for the Production of Documents and Notice of Subpoena for Deposition to Dr. William T. Colwell by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc. (Haney, Megan) (Entered: 11/13/2015) |
NOTICE of Subpoena for the Production of Documents and Notice of Subpoena for Deposition to Dr. Joseph I. DeGraw by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc. (Haney, Megan) (Entered: 11/13/2015) |
NOTICE of Subpoena for the Production of Documents and Notice of Subpoena for Deposition to Dr. Pablo J. Cagnoni by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc. (Haney, Megan) (Entered: 11/13/2015) |
NOTICE to Take Deposition of Francis M. Sirotnak on December 11, 2015 at 9:00 a.m. filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 11/13/2015) |
NOTICE of Subpoena for the Production of Documents and Notice of Subpoena for Deposition to Marina Larson by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc. (Haney, Megan) (Entered: 11/17/2015) |
MOTION for Pro Hac Vice Appearance of Attorney Isaac S. Ashkenazi, Joseph M. OMalley, Jr., and Bruce M. Wexler - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Mayo, Andrew) (Entered: 11/24/2015) |
MOTION for Pro Hac Vice Appearance of Attorney Angela C. Ni and Simon F. Kung - filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Maguire, Lauren) (Entered: 12/04/2015) |
NOTICE OF SERVICE of Plaintiffs Response to Defendants Third Set of Interrogatories to Plaintiffs (Nos. 12-14) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Maguire, Lauren) (Entered: 12/07/2015) |
STIPULATION and Order to Amend Scheduling Order by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Maguire, Lauren) (Entered: 12/15/2015) |
NOTICE OF SERVICE of (1) Objections by Marina Larson to Non-Party Subpoena; (2) Objections by Owen A. OConnor to Non-Party Subpoena; (3) Objections by Pablo J. Cagnoni to Non-Party Subpoena; (4) Objections by William T. Colwell to Non-Party Subpoena; and (5) Objections by Joseph I. Degraw to Non-Party Subpoena filed by Allos Therapeutics Inc..(Maguire, Lauren) (Entered: 12/30/2015) |
NOTICE OF SERVICE of Plaintiff SRI International, Inc.s Response to Defendants Notice of Rule 30(b)(6) Deposition; Plaintiff Southern Research Institutes Response to Defendants Notice of Rule 30(b)(6) Deposition; Plaintiff Sloan-Kettering Institute for Cancer Researchs Response to Defendants Notice of Rule 30(b)(6) Deposition; and Plaintiff Allos Therapeutics, Inc.s Response to Defendants Notice of Rule 30(b)(6) Deposition filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Maguire, Lauren) (Entered: 12/31/2015) |
NOTICE OF SERVICE of (i) Plaintiffs Notice of Deposition of Teva Pharmaceuticals USA, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6); (ii) Plaintiffs Notice of Deposition of Fresenius Kabi USA, LLC Pursuant to Fed. R. Civ. P. 30(b)(6); and (iii) Plaintiffs Notice of Deposition of Sandoz Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Maguire, Lauren) (Entered: 01/06/2016) |
STIPULATION regarding discovery and infringement between Plaintiffs and Defendant Fresenius Kabi USA, LLC by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Maguire, Lauren) (Entered: 01/11/2016) |
STIPULATION regarding discovery and infringement between Plaintiffs and Defendant Sandoz Inc. by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Maguire, Lauren) (Entered: 01/11/2016) |
STIPULATION regarding discovery and infringement between Plaintiffs and Defendant Teva Pharmaceuticals USA, Inc. by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute. (Maguire, Lauren) (Entered: 01/11/2016) |
SO ORDERED Granting 120 Stipulation Regarding Discovery and Infringement Between Plaintiffs and Defendant Teva Pharmaceuticals USA, Inc., filed by Southern Research Institute, Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research. Signed by Judge Richard G. Andrews on 1/12/2016. (nms) (Entered: 01/12/2016) |
SO ORDERED Granting 119 Stipulation Regarding Discovery and Infringement Between Plaintiffs and Defendant Sandoz, Inc., filed by Southern Research Institute, Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research. Signed by Judge Richard G. Andrews on 1/12/2016. (nms) (Entered: 01/12/2016) |
SO ORDERED Granting 118 Stipulation Regarding Discovery and Infringement Between Plaintiffs and Defendant Fresenius Kabi USA, LLC, filed by Southern Research Institute, Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research. Signed by Judge Richard G. Andrews on 1/12/2016. (nms) (Entered: 01/12/2016) |
ORDER Setting Mediation Conferences: Mediation conferences are scheduled for Thursday, July 28, 2016, Friday, July 29, 2016 and Monday, August 1, 2016 beginning at 10:00 a.m. each day in Judge Thynges Courtroom 2B. By no later than the due date for submissions, Thursday, July 14, 2016, the parties shall identify the date each defendant/defendant group shall mediate. SEE ORDER FOR FURTHER DETAILS. Signed by Judge Mary Pat Thynge on 1/14/16. (cak) (Entered: 01/14/2016) |
NOTICE OF SERVICE of Plaintiffs Supplemental Responses to Defendants First Set of Interrogatories (No. 1) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Maguire, Lauren) (Entered: 01/25/2016) |
NOTICE OF SERVICE of (1) Defendants Supplemental Invalidity Contentions; (2) Defendant Teva Pharmaceuticals USA, Inc.s Supplemental Objections and Responses to Plaintiffs Common Interrogatories Nos. 2 and 6; (3) Defendant Fresenius Kabi USA, LLCs Supplemental Objections and Responses to Plaintiffs Common Interrogatories (Nos. 2 and 6); and (4) Defendant Sandoz Inc.s Supplemental Objections and Responses to Plaintiffs Common Interrogatories Nos. 2 and 6 filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 02/05/2016) |
NOTICE OF SERVICE of Plaintiffs Supplemental Responses to Defendants First Set of Interrogatories (No. 3) filed by Allos Therapeutics Inc., SRI International Inc., Sloan-Kettering Institute for Cancer Research, Southern Research Institute.(Mayo, Andrew) (Entered: 02/05/2016) |
STIPULATION and Order to Amend Scheduling Order - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Haney, Megan) Modified on 2/9/2016 (nms). (Entered: 02/08/2016) |
NOTICE requesting Clerk to remove Lesley M. Hamming as co-counsel. Reason for request: No Longer Affiliated with Winston & Strawn LLP. (Haney, Megan) (Entered: 02/24/2016) |
STIPULATION TO EXTEND TIME for Close of Fact Discovery to March 7, 2016 - filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Haney, Megan) (Entered: 03/04/2016) |
STIPULATION and Proposed Order by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc.. (Phillips, John) (Entered: 03/07/2016) |
SO ORDERED Granting 133 Stipulation and Order (see Stipulation for further details). Signed by Judge Richard G. Andrews on 3/8/2016. (nms) (Entered: 03/08/2016) |
NOTICE OF SERVICE of Plaintiffs Second Supplemental Responses to Defendants First Set of Interrogatories (No. 3) filed by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research.(Maguire, Lauren) (Entered: 03/28/2016) |
NOTICE OF SERVICE of Expert Report of Michael L. Grossbard, M.D. filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 04/04/2016) |
NOTICE of Change of Address by Lauren E. Maguire (Maguire, Lauren) (Entered: 05/04/2016) |
NOTICE OF SERVICE of Rebuttal Expert Report of Andrei R. Shustov, M.D. filed by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research.(Maguire, Lauren) (Entered: 05/09/2016) |
Joint MOTION to Lift Stay of Action Against Dr. Reddys for Limited Purpose of Entry of Stipulation and Order - filed by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research. (Balick, Steven) Modified on 5/27/2016 (nms). (Entered: 05/26/2016) |
STIPULATION with respect to certain claims, counterclaims, and defenses as between Plaintiffs and Dr. Reddys, by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research. (Balick, Steven) (Entered: 05/26/2016) |
SO ORDERED Granting 139 Joint MOTION to Lift Stay of Action Against Dr. Reddys for Limited Purpose of Entry of Stipulation and Order, filed by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research. Signed by Judge Richard G. Andrews on 5/31/2016. (nms) (Entered: 05/31/2016) |
SO ORDERED Granting 140 Stipulation and Order, filed by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research (see Stipulation for further details). Signed by Judge Richard G. Andrews on 5/31/2016. (nms) (Entered: 05/31/2016) |
NOTICE OF SERVICE of Reply Expert Report of Michael L. Grossbard, M.D. filed by Fresenius Kabi USA LLC, Sandoz Inc., Teva Pharmaceuticals USA Inc..(Haney, Megan) (Entered: 06/13/2016) |
STIPULATION of Dismissal as to Sandoz Inc., by Allos Therapeutics Inc.. (Maguire, Lauren) Modified on 6/13/2016 (nms). (Entered: 06/13/2016) |
SO ORDERED Granting 144 Stipulation of Dismissal as to Sandoz, Inc., filed by Allos Therapeutics Inc. (*Party Sandoz Inc. terminated). Signed by Judge Richard G. Andrews on 6/13/2016. (nms) (Entered: 06/13/2016) |
PROPOSED Consent Judgment and Dismissal Order of Teva Pharmaceuticals USA, Inc., by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research. (Maguire, Lauren) Modified on 7/1/2016 (nms). (Entered: 07/01/2016) |
SO ORDERED Granting 146 Proposed Consent Judgment and Dismissal Order. Signed by Judge Richard G. Andrews on 7/1/2016. (nms) (Entered: 07/01/2016) |
PROPOSED Consent Judgment and Dismissal Order for Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc., by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research. (Maguire, Lauren) Modified on 7/7/2016 (nms). (Entered: 07/05/2016) |
CONSENT Judgment and Dismissal Order (as to Dr Reddys Laboratories Ltd. and Dr Reddys Laboratories Inc.. Signed by Judge Richard G. Andrews on 7/7/2016. (nms) (Entered: 07/07/2016) |
STIPULATION TO EXTEND TIME Extend Expert Discovery to July 21, 2016 - filed by Fresenius Kabi USA LLC. (Phillips, John) (Entered: 07/08/2016) |
STIPULATION Requesting that all Remaining Dates in the Case Schedule be Vacated, by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research. (Balick, Steven) (Entered: 07/20/2016) |
PROPOSED Consent Judgment and dismissal order with respect to Fresenius Kabi USA, LLC, by Allos Therapeutics Inc., Sloan-Kettering Institute for Cancer Research. (Balick, Steven) Modified on 8/17/2016 (nms). (Entered: 08/16/2016) |
CONSENT JUDGMENT and Dismissal Order. Signed by Judge Richard G. Andrews on 8/17/2016. (nms) (Entered: 08/17/2016) |
Timeline
filed_date
closed_date
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2015
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2016
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2017
Feb
Mar
Apr
May
Patents In Case